Proven and experienced leader in the fields of oncology and hematology research and drug development within industry (>20 yrs experience) and academia (>8 yrs experience). Leader of preclinical small and large molecule drug discovery programs (immunotherapeutics, kinases, chemokine receptors) from target identification, IND filings through FIH . Previously, preclinical lead for postmarketed product support of hematopoietic growth factors (Aranesp, Epogen, Nplate - multi-billion dollar products). Provides strategic guidance to Executive Leadership on discovery initiatives and portfolio asset management. Strong leader of teams across functions and sites coupled with excellent written and verbal communication skills including scientific presentations/publications and regulatory communications (FDA and international regulatory authorities). Experienced manager of Directors and Scientists.